147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
More posts

Vaccine model based on recombinant hydrophobic protein and saponin

The Bd37 is an erythrocyte binding protein anchored at the surface of the parasite Babesia divergens. B. divergens is an Apicomplexa parasite, mostly […]

Cellular fibronectin toolset

Expression vectors encoding human 'cellular' fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]

Real time no measurement

Real time constant amperometric detection of NO in tissues/cells. This gaseous neurotransmitter has a very short half-life (*5 s) and is usually […]

Rat mesothelial cell line m2-3

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 284 days of induction with crocidolite […]

Rat mesothelioma cell line f5-t1

Neoplastic rat cell line isolated from tumor masses (peritoneal mesothelioma) collected in the peritoneal cavity of a female rat (F344) after 392 days […]

Rat mesothelial cell line m2-2

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a male rat (Fischer F344) after 270 days of induction with crocidolite […]

Rat mesothelioma cell line m5-t1

Neoplastic rat cell line isolated from tumor masses (peritoneal mesothelioma) collected in the peritoneal cavity of a male rat (F344) after 378 days […]

More posts

You might also be interested in